Alvogen, Inc.
Industry
- Pharmaceuticals
- Generic Drugs
- OTC, Consumer
Other Names/Subsidiaries
- Alvogen Korea Co., Ltd, Lotus Pharmaceuticals
Latest on Alvogen, Inc.
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Antibiotics Firm Agrees To Go Private F
In the ever-evolving global generics and biosimilars industry, one constant that can be relied upon is change. Even as the upheaval of the COVID-19 pandemic recedes, fresh political and economic press
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Biocytogen Licenses Antibodies For
Zydus Lifesciences Limited expects gains from a second quarter launch of a generic to Bristol Myers Squibb Company ’s blockbuster oncology drug Revlimid (lenalidomide) to extend beyond the fourth qu